Back to BlackRock, Inc. BlackRock, Inc.

IRDIRD
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in OCUPHIRE PHARMA INC

BlackRock, Inc. holds 3.1M shares of IRD (OCUPHIRE PHARMA INC), worth $12.8M as of 2026-Q2. The position was increased (+2009.4% shares). IRD represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$12.8M

Current Shares

3.1M

Total Value Change

+$12.7M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+2009.4%
$12.8M0.0%$4.11
45
2026-Q1
Increased
147,740
+4.1%
$672,2170.0%$4.55
17
2025-Q4
Increased
141,897
+207.8%
$285,2130.0%$2.01
26
2025-Q3
Unchanged
46,094
0.0%
$76,0550.0%$1.65
0
2025-Q2
Decreased
46,094
-57.5%
$43,4250.0%$0.94
0
2025-Q1
Decreased
108,527
-1.1%
$106,5520.0%$0.98
0
2024-Q4
Increased
109,721
+0.4%
$130,5690.0%$1.19
15
2024-Q3
First report
109,323
-
$143,2130.0%$1.31
0

Other major holders of IRD: ADAGE CAPITAL PARTNERS GP, L.L.C., BALYASNY ASSET MANAGEMENT L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used